Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 11, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 172
- −5 vs. Q1 2022
- Portfolio value
- $7.07B
- −$1.54B (−17.9%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AUPHAurinia Pharmaceuticals Inc. | COM | 2,671,413 | $26.8M | 0.4% | +265,588+11.0% | Added | History |
| ACCDAccolade, Inc. | COM | 3,634,886 | $26.9M | 0.4% | +253,379+7.5% | Added | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 337,434 | $26.9M | 0.4% | −7,666−2.2% | Reduced | History |
| ESPREsperion Therapeutics, Inc. | COM | 4,235,264 | $26.9M | 0.4% | −63,900−1.5% | Reduced | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 266,087 | $28.0M | 0.4% | −4,647−1.7% | Reduced | History |
| ADPTAdaptive Biotechnologies Corp | COM | 3,539,055 | $28.6M | 0.4% | +393,762+12.5% | Added | History |
| BAXBaxter International Inc | Stock | 457,819 | $29.4M | 0.4% | −32,061−6.5% | Reduced | History |
| EXASExact Sciences Corp | COM | 758,023 | $29.9M | 0.4% | +38,720+5.4% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 817,141 | $31.3M | 0.4% | +97,659+13.6% | Added | History |
| ALGNAlign Technology Inc | COM | 135,240 | $32.0M | 0.5% | −6,111−4.3% | Reduced | History |
| VEEVVeeva Systems Inc | Stock | 168,776 | $33.4M | 0.5% | +8,175+5.1% | Added | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 702,068 | $34.2M | 0.5% | +577,107+461.8% | Added | History |
| OMOutset Medical, Inc. | COM | 2,326,718 | $34.6M | 0.5% | +309,559+15.3% | Added | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 630,439 | $34.7M | 0.5% | −29,630−4.5% | Reduced | History |
| IQVIQVIA Holdings Inc. | Stock | 168,598 | $36.6M | 0.5% | +9,478+6.0% | Added | History |
| GMEDGlobus Medical Inc | Stock | 656,681 | $36.9M | 0.5% | −88,573−11.9% | Reduced | History |
| SILKSilk Road Medical Inc | COM | 1,047,286 | $38.1M | 0.5% | +1,719+0.2% | Added | History |
| TMOThermo Fisher Scientific Inc. | Stock | 71,818 | $39.0M | 0.6% | −815−1.1% | Reduced | History |
| IDXXIDEXX Laboratories Inc | COM | 115,773 | $40.6M | 0.6% | −2,037−1.7% | Reduced | History |
| ABMDAbiomed Inc | COM | 169,509 | $42.0M | 0.6% | +19,331+12.9% | Added | History |
| HALOHalozyme Therapeutics, Inc. | COM | 971,300 | $42.7M | 0.6% | −52,900−5.2% | Reduced | History |
| PFEPfizer Inc | Stock | 835,684 | $43.8M | 0.6% | +789,184+1,697.2% | Added | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 91,161 | $45.1M | 0.6% | +19,152+26.6% | Added | History |
| CNCCentene Corp | Stock | 545,903 | $46.2M | 0.7% | −114,732−17.4% | Reduced | History |
| OMCLOmnicell, Inc. | COM | 425,823 | $48.4M | 0.7% | +63,491+17.5% | Added | History |
| HCAHCA Healthcare, Inc. | COM | 292,771 | $49.2M | 0.7% | −7,426−2.5% | Reduced | History |
| CRLCharles River Laboratories International, Inc. | COM | 231,069 | $49.4M | 0.7% | +104,663+82.8% | Added | History |
| CICigna Group | Stock | 193,657 | $51.0M | 0.7% | −65,489−25.3% | Reduced | History |
| CDNACareDx, Inc. | COM | 2,537,524 | $54.5M | 0.8% | +226,348+9.8% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,206,422 | $54.6M | 0.8% | +107,710+9.8% | Added | History |
| EXELExelixis, Inc. | COM | 2,678,500 | $55.8M | 0.8% | −40,500−1.5% | Reduced | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 922,005 | $56.0M | 0.8% | −4,900−0.5% | Reduced | History |
| MDTMedtronic plc | Stock | 645,506 | $57.9M | 0.8% | −10,524−1.6% | Reduced | History |
| AMEDAmedisys Inc | COM | 585,154 | $61.5M | 0.9% | +9,023+1.6% | Added | History |
| EVHEvolent Health, Inc. | CL A | 2,018,521 | $62.0M | 0.9% | −593,742−22.7% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 3,383,262 | $65.9M | 0.9% | +72,600+2.2% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 4,032,262 | $67.5M | 1.0% | +113,300+2.9% | Added | History |
| HUMHumana Inc | Stock | 145,309 | $68.0M | 1.0% | −2,133−1.4% | Reduced | History |
| DXCMDexcom Inc | COM | 928,508 | $69.2M | 1.0% | −11,092−1.2% | ReducedConverted for a 4-for-1 split | History |
| MOHMolina Healthcare, Inc. | COM | 248,313 | $69.4M | 1.0% | −54,484−18.0% | Reduced | History |
| SWAVShockwave Medical, Inc. | COM | 370,699 | $70.9M | 1.0% | −27,878−7.0% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 3,621,562 | $71.4M | 1.0% | +69,786+2.0% | Added | History |
| MYOVMyovant Sciences Ltd. | COM | 5,919,639 | $73.6M | 1.0% | +60,600+1.0% | Added | History |
| INSPInspire Medical Systems, Inc. | COM | 407,057 | $74.4M | 1.1% | +9,551+2.4% | Added | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 1,315,873 | $77.9M | 1.1% | +199,365+17.9% | Added | History |
| OPCHOption Care Health, Inc. | COM NEW | 2,887,259 | $80.2M | 1.1% | −345,528−10.7% | Reduced | History |
| PODDInsulet Corp | Stock | 386,335 | $84.2M | 1.2% | −11,854−3.0% | Reduced | History |
| BDXBecton Dickinson & Co | Stock | 342,982 | $84.6M | 1.2% | −53,423−13.5% | Reduced | History |
| SRPTSarepta Therapeutics, Inc. | COM | 1,139,455 | $85.4M | 1.2% | −11,704−1.0% | Reduced | History |
| FATEFate Therapeutics Inc | COM | 3,550,086 | $88.0M | 1.2% | −26,400−0.7% | Reduced | History |
| ARVNArvinas, Inc. | COM | 2,124,276 | $89.4M | 1.3% | −54,977−2.5% | Reduced | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 4,062,792 | $90.1M | 1.3% | −66,500−1.6% | Reduced | History |
| Radius Health, Inc.750469207 | COM NEW | 8,796,538 | $91.2M | 1.3% | +477,824+5.7% | Added | – |
| DHRDanaher Corp | Stock | 364,036 | $92.3M | 1.3% | +6,974+2.0% | Added | History |
| SYKStryker Corp | Stock | 477,634 | $95.0M | 1.3% | +37,409+8.5% | Added | History |
| SAGESage Therapeutics, Inc. | COM | 2,973,178 | $96.0M | 1.4% | −79,226−2.6% | Reduced | History |
| EWEdwards Lifesciences Corp | Stock | 1,010,627 | $96.1M | 1.4% | +97,842+10.7% | Added | History |
| ELVElevance Health, Inc. | Stock | 208,500 | $100.6M | 1.4% | −203,137−49.3% | Reduced | History |
| AXNXAxonics, Inc. | COM | 2,313,852 | $131.1M | 1.9% | +264,647+12.9% | Added | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 917,907 | $143.2M | 2.0% | +162,926+21.6% | Added | History |
| BSXBoston Scientific Corp | Stock | 3,850,171 | $143.5M | 2.0% | −63,776−1.6% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 1,058,186 | $154.3M | 2.2% | −171,377−13.9% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 302,044 | $155.1M | 2.2% | −3,657−1.2% | Reduced | History |
| ABTAbbott Laboratories | Stock | 1,573,807 | $171.0M | 2.4% | −49,120−3.0% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 909,348 | $182.5M | 2.6% | +289,280+46.7% | Added | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 3,349,379 | $191.2M | 2.7% | −80,240−2.3% | Reduced | History |
| INCYIncyte Corp | COM | 2,773,377 | $210.7M | 3.0% | −74,023−2.6% | Reduced | History |
| MRNAModerna, Inc. | Stock | 1,577,351 | $225.3M | 3.2% | −61,998−3.8% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 2,844,305 | $277.3M | 3.9% | −179,146−5.9% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 1,176,136 | $331.4M | 4.7% | −304,117−20.5% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 933,803 | $349.6M | 4.9% | −19,435−2.0% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 9,776,528 | $361.9M | 5.1% | −141,545−1.4% | Reduced | History |
Sold out since Q1 2022 (15)
Positions held at the end of Q1 2022 that are gone from this filing.
| Security | Class | Shares in Q1 2022 | Value in Q1 2022 | % of portfolio in Q1 2022 | History |
|---|---|---|---|---|---|
| XRAYDentsply Sirona Inc. | Stock | 159,129 | $7.83M | 0.1% | History |
| BHVNBiohaven Ltd. | COM | 39,207 | $4.65M | 0.1% | History |
| BNRBurning Rock Biotech Ltd | SPONSORED ADS | 438,869 | $4.08M | <0.1% | History |
| KYMRKymera Therapeutics, Inc. | COM | 52,400 | $2.22M | <0.1% | History |
| BPMCBlueprint Medicines Corp | COM | 26,000 | $1.66M | <0.1% | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 54,500 | $1.32M | <0.1% | History |
| MRTXMirati Therapeutics, Inc. | COM | 14,800 | $1.22M | <0.1% | History |
| Genetron Hldgs Ltd37186H100 | ADS | 535,822 | $1.17M | <0.1% | – |
| QTRXQuanterix Corp | COM | 35,704 | $1.04M | <0.1% | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 46,200 | $517.0K | <0.1% | History |
| TSMTaiwan Semiconductor Manufacturing Co Ltd | ADR | 619 | $65.0K | <0.1% | History |
| UMCUnited Microelectronics Corp | SPON ADR NEW | 2,698 | $25.0K | <0.1% | History |
| NIONIO Inc. | ADR | 1,093 | $23.0K | <0.1% | History |
| PDDPDD Holdings Inc. | SPONSORED ADS | 466 | $19.0K | <0.1% | History |
| BILIBilibili Inc. | SPONS ADS REP Z | 744 | $19.0K | <0.1% | History |